Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT-Reference-Cited by-同舟云学术

Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT

Published:2014-09-25 Issue:5 Volume:136 Page:E326-E339
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Doberstein Kai¹,Harter Patrick N.²,Haberkorn Uwe³,Bretz Niko P.¹,Arnold Bernd⁴,Carretero Rafael⁴,Moldenhauer Gerhard¹,Mittelbronn Michel²,Altevogt Peter¹

Affiliation:

1. Translational Immunology, D015, Tumor Immunology Programme German Cancer Research Center (DKFZ); Heidelberg Germany

2. Edinger Institute (Neurological Institute), Goethe University Frankfurt; Frankfurt Germany

3. Department of Nuclear Medicine; University Hospital Heidelberg; Heidelberg Germany

4. Molecular Immunology, D050, Tumor Immunology Programme German Cancer Research Center (DKFZ); Heidelberg Germany

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin;Moos;Nature,1988

2. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas;Fogel;Lancet,2003

3. L1 is associated with micrometastatic spread and poor outcome in colorectal cancer;Kaifi;Mod Pathol,2007

4. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells;Sebens Muerkoster;Oncogene,2007

5. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma;Ben;Ann Surg Oncol,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating TCGA and single-cell sequencing data for colorectal cancer: a 10-gene prognostic risk assessment model;Discover Oncology;2023-09-13

2. Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancer;Gynecologic Oncology;2023-07

3. L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary;Communications Biology;2022-12-12

4. Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma;Cancers;2022-11-03

5. Endometrial cancer: molecular classification and future treatments;BMJ Medicine;2022-10